Neglected Tropical Diseases (NTDs) — including lymphatic filariasis, schistosomiasis, and trachoma — affect over one billion people worldwide, trapping communities in cycles of poverty and poor health. Eliminating these diseases depends on mass drug administration (MDA) campaigns that must reach millions of people in endemic regions.
Yet planning and executing MDAs is complex. Traditional approaches often rely on incomplete population data, leaving some settlements underserved while over-supplying others. Without strong monitoring systems, programs struggle to know if they have achieved the high coverage thresholds needed for elimination.
Akros helps ministries of health overcome these challenges by embedding geospatial microplanning, community-based surveillance, and digital monitoring into national NTD programs. Our role is to make large-scale campaigns more effective, equitable, and sustainable.
01
Geospatial Microplanning
Use maps and settlement data to ensure every community is included in drug distribution plans.
02
Integrated Surveillance
Capture disease and behavior indicators at community and school level, linked directly to national DHIS2 systems.
03
Real-Time Monitoring
Equip supervisors and managers with dashboards to track MDA progress during campaigns.
04
Government Partnership & Ownership
Design systems within national structures to be maintained and scaled beyond project timelines.
Zambia
National leadership in LF, schistosomiasis, and trachoma programs — delivering millions of treatments across 80+ districts with sustained therapeutic coverage.
Kenya and Mali
END Fund partnerships strengthened MDA campaigns with precision targeting and real-time monitoring.
Akros delivers NTD programming in partnership with ministries of health, The END Fund, ASCEND, WHO, UNICEF, and other global partners.
eCHIS and Reveal set to integrate to geo-enable integrated health campaigns in Kenya
Akros, with support from the END Fund through the Deworming Innovation Fund, worked with the Division of Vector Borne and Neglected Tropical Diseases (DVB…
- LF MDA Zambia – ASCEND Program Summary
- Akros played a pivotal role in Zambia’s final rounds of lymphatic filariasis mass drug administration (MDA), providing the Ministry of Health with critical technical and financial support at a time when COVID-19 disruptions threatened campaign continuity. By strengthening data systems, training and equipping community drug distributors, and mobilizing traditional, religious, and civic leaders, Akros helped ensure medicines reached even the most remote and vulnerable communities. This collaborative approach not only achieved high coverage across 80 districts but also transferred capacity to local health offices, leaving Zambia’s health system stronger and better prepared to sustain progress toward eliminating lymphatic filariasis as a public health threat.